| Literature DB >> 18028551 |
Miyako Kusano1, Atsushi Fukushima, Masanori Arita, Pär Jonsson, Thomas Moritz, Makoto Kobayashi, Naomi Hayashi, Takayuki Tohge, Kazuki Saito.
Abstract
BACKGROUND: Metabolites are not only the catalytic products of enzymatic reactions but also the active regulators or the ultimate phenotype of metabolic homeostasis in highly complex cellular processes. The modes of regulation at the metabolome level can be revealed by metabolic networks. We investigated the metabolic network between wild-type and 2 mutant (methionine-over accumulation 1 [mto1] and transparent testa4 [tt4]) plants regarding the alteration of metabolite accumulation in Arabidopsis thaliana.Entities:
Mesh:
Substances:
Year: 2007 PMID: 18028551 PMCID: PMC2233643 DOI: 10.1186/1752-0509-1-53
Source DB: PubMed Journal: BMC Syst Biol ISSN: 1752-0509
Figure 1The partial least square-discriminate analysis (PLS-DA) score scatter plot of the first 2 components for WT and 2 mutants, . Dotted circles represent individual plant samples. This PLS-DA analysis represents the differentiation of 53 samples (WT, n = 17; mto1, n = 16 [13 samples from biological replicates and 3 samples from analytical replicates]; and tt4, n = 20). The symbols correspond as follows: red square, wild-type (WT); blue diamond, methionine-over accumulation 1 (mto1); green circle, transparent testa4 (tt4). The PLS-DA model shows 3 significant components according to cross-validation. The explained variation in the X-matrix (R2X) and the Y-matrix (R2Y) is 0.60 and 0.86, respectively, and the predictive ability according to 7-fold cross-validation (Q2Y) is 0.80.
Figure 2Changes in the levels of metabolites in (A) . The changes in metabolite contents were calculated by dividing the metabolite level in the mutant with that in the WT. The level of significance was set at p < 0.05. The metabolites with gray characters were undetectable. Abbreviations: 3-PGA, 3-phosphoglycerate; AA, ascorbate; a-KG, alpha-ketoglutarate; Ala, alanine; Arg, arginine; Asn, asparagine; Asp, aspartate; a-Tocop, alpha-tocopherol; b-Ala, beta-alanine; b-Sito, beta-sitosterol; Camp, campesterol; Chol, cholesterol; CitA, citrate; Cys, cysteine; dhAA, dehydroascorbate; Dihydroxyacetone-P, dihydroxy-acetone-phosphate; D-Ribulose-1,5-P, D-ribulose-1,5-diphosphate; Duracil, dihydrouracil; EA, ethanolamine; Ery, erythritol; FatA C14:0, n-tetradecanoate; FatA C16:0, n-hexadecanoate; FatA C18:0, stearate; FatA C18:2, linoleate; FatA C18:3, linolenate; FatA C24:0, n-tetracosanoate; Fru, fructose; Fru-1,6-bisP, fructose-1,6-biphosphate; Fru6P, fructose 6-phosphate; FumA, fumarate; GABA, gamma-amino-n-butyrate; GalactonicA, galactonate; GalacturonicA, galacturonate; GalOH, galactitol; Glc, glucose; Glc6P, glucose-6-phosphate; Gln, glutamine; Glu, glutamate; Glu1,6An, 1,6-anhydro-glucose; Gly, glycine; Gly2P, glycerol-2-phosphate; Gly3P, glycerol-3-phosphate; GlycA, glycerate; hCys, homocysteine; hSer, homoserine; Ile, isoleucine; IndACN,1H-indole-3-acetonitrile; Ino, myo-inositol; Ino1P, myo-inositol-1-phosphate; LacA, lactate; Leu, leucine; Lys, lysine; M, maleate; MalA, malate; Man, mannose; Man6P, mannose-6-phosphate; Met, methionine; MetSulf, methionine sulfone; NicA, nicotinic Acid; NicAm, nicotianamine; OAS, O-acetyl serine; Orn, Ornithine; OrnNAc, N-acetyl-ornithine; P, phosphate; Phe, phenylalanine; PIP, pipecolate; Pro, proline; Put, putrescine; Raf, raffinose; Rha, rhamnose; SAM, S-adenosyl-methionine; Ser, serine; ShikA, shikimate; SinaA, sinapate; Spd, spermidine; Stigm, stigmasterol; Suc, sucrose; SucA, succinate; Thr, threonine; ThrA, threonate; ThrAL, trans-threonic acid-1,4-lactone; Tre, trehalose; Trp, tryptophan; Tyr, tyrosine; Ura, uracil; Val, valine.
Figure 3Heat-map matrices of metabolite correlation in (A) WT, (B) . The metabolites are classified into 6 groups: amino acids, fatty acids, organic acids, N-containing compound, sugars, steroids and unknown compounds. Each square indicates r(Pearson's correlation coefficient of a pair of metabolites), and the value of ris represented by the intensity of blue or red colors as indicated on the color scale.
Figure 4The numbers of common metabolite correlations conserved in 3 genotypes. The Venn diagram of the significant correlation pairs in WT, mto1, and tt4. The significance of correlations observed were determined as |r| ≥ 0.80 (p < 1.2 × 10-4, n = 17) for WT, |r| ≥ 0.85 (p < 2.3 × 10-4, n = 13) for mto1, and |r| ≥ 0.75 (p < 1.4 × 10-4, n = 20) for tt4.
Metabolite correlations focused on malate and sinapate.
| Metabolite | Metabolite | Pathway | |||
| Malate | Maleate | 0.80 | 0.46 | 0.91 | TCA |
| Succinate | 0.70 | -0.06 | TCA | ||
| Fumarate | 0.83 | 0.07 | 0.90 | TCA | |
| Citrate | 0.92 | 0.79 | 0.87 | TCA | |
| Phenylalanine | 0.45 | -0.01 | Shikimate | ||
| Shikimate | 0.81 | 0.57 | 0.92 | Shikimate | |
| Tyramine | 0.44 | 0.10 | Shikimate | ||
| Tyrosine | 0.48 | 0.48 | Shikimate | ||
| Sinapate | 0.50 | 0.06 | Shikimate | ||
| Sinapate | Maleate | 0.74 | 0.59 | TCA | |
| Succinate | 0.85 | 0.74 | 0.86 | TCA | |
| Fumarate | 0.75 | 0.87 | 0.90 | TCA | |
| Citrate | 0.36 | 0.09 | TCA | ||
| Malate | 0.50 | 0.06 | Shikimate | ||
| Phenylalanine | 0.74 | 0.33 | Shikimate | ||
| Shikimate | 0.72 | 0.38 | Shikimate | ||
| Tyramine | 0.80 | 0.11 | 0.91 | Shikimate | |
| Tyrosine | 0.71 | 0.29 | Shikimate |
Boldface characters represent the unique correlations observed only in tt4. The unique correlations in tt4 are defined as r> 0.85 in tt4 and as r< 0.80 in WT and mto1. Abbreviations: TCA, tricarboxylic acid.
Figure 5The interconnections in the pathways of central metabolism and aromatic amino acids for (A) WT and (B) . The metabolites whose levels changed less than 10% (p < 0.05) in tt4/WT are indicated with blue characters in (B); the metabolites with black characters in (B) had no significant changes; and the metabolites with gray characters were undetectable. The gray arrows indicate the metabolic pathways. The curved lines show correlations between metabolite pairs. The thickness of the edges between the metabolites represents the significance of correlations (r> 0.88). Although the sinapoylmalate level in tt4 did not increase, the correlations of malate with aromatic compounds were intensified in the tt4 mutant, indicating possible adaptive response to UV stress under the flavonoid-deficient tt4 mutant by reconfiguration of the networks in tt4. Metabolites with the asterisk (*) were quantified by using LC-Q-TOF/MS analysis (see Additional File 3). Abbreviations: CHS, chalcone synthase; p-Coumarate, 4-Hydroxycinnamic acid.
Figure 6The metabolite correlation networks. (A) Significant metabolite correlation networks in WT plants (|r| ≥ 0.8, n = 17, p < 1.2 × 10-4). Each vertex corresponds to a metabolite or mass spectral tag (MSTs). The metabolites or MSTs with significant correlations are linked together. The colors of nodes represent the identified peaks (yellow circle), annotated peaks (red triangle) and MSTs (red square). The colors of the edges between nodes display the positive correlation (purple line) and the negative correlation (green line). (B) The common correlation pairs that are observed among WT, mto1, and tt4. (C) Expansions of the common network modules contain the following: (1) fructose-glucose, (2) cholesterol-campesterol and cholesterol-beta-sitosterol, and (3) succinate-fumarate and serine- glutamate.
Significant correlations of identified metabolites conserved among 3 genotypes.
| Metabolite | Metabolite | ||||||
| Fructose | Glucose | 0.94 | 0.0000 | 0.94 | 0.0000 | 0.94 | 0.0000 |
| Cholesterol | Campesterol | 0.96 | 0.0000 | 0.97 | 0.0000 | 0.96 | 0.0000 |
| Valine | beta-Alanine | 0.92 | 0.0000 | 0.87 | 0.0001 | 0.96 | 0.0000 |
| Lysine | Tyramine | 0.91 | 0.0000 | 0.94 | 0.0000 | 0.98 | 0.0000 |
| Serine | Glutamate | 0.90 | 0.0000 | 0.87 | 0.0001 | 0.93 | 0.0000 |
| Aspartate | Shikimate | 0.90 | 0.0000 | 0.93 | 0.0000 | 0.97 | 0.0000 |
| Campesterol | beta-Sitosterol | 0.90 | 0.0000 | 0.98 | 0.0000 | 0.97 | 0.0000 |
| Succinate | Glutamate | 0.89 | 0.0000 | 0.85 | 0.0002 | 0.92 | 0.0000 |
| Phenylalanine | Tyramine | 0.88 | 0.0000 | 0.89 | 0.0001 | 0.95 | 0.0000 |
| Succinate | Fumarate | 0.87 | 0.0000 | 0.86 | 0.0002 | 0.86 | 0.0000 |
| Glycerol-3-P | Inositol-1-P | 0.85 | 0.0000 | 0.93 | 0.0000 | 0.75 | 0.0001 |
| Isoleucine | Tyramine | 0.84 | 0.0000 | 0.86 | 0.0002 | 0.90 | 0.0000 |
| Glutamate | Adenosine-5-P | 0.84 | 0.0000 | 0.86 | 0.0002 | 0.77 | 0.0001 |
| Valine | Threonine | 0.83 | 0.0000 | 0.88 | 0.0001 | 0.96 | 0.0000 |
| Cholesterol | beta-Sitosterol | 0.81 | 0.0001 | 0.98 | 0.0000 | 0.97 | 0.0000 |
| Glutamine | Adenosine-5-P | 0.81 | 0.0001 | 0.92 | 0.0000 | 0.83 | 0.0000 |
The significant level of the metabolite correlation was set at p < 0.001. Only pairs comprising identified metabolites are listed. The metabolites were defined as those identified on comparison with mass spectra and retention indices (RIs) from the library databases (Golm Metabolome Database [30] and our own library) and with authentic standards. Abbreviations: Glycerol-3-P, glycerol-3-phosphate; Inositol-1-P, myo-inositol-1-phosphate; Adenosine-5-P, adenosine-5-monophosphate.
Z-score of metabolite correlations (ZMC) found in (A) mto1 and (B) tt4 (r≥ 0.8).
| 1066 | MST | 3.45 | ≤0.001 |
| 1727 | MST | 2.56 | ≤0.05 |
| 1823 | Methionine sulfone | 2.42 | ≤0.05 |
| 2057 | MST | 2.07 | ≤0.05 |
| 2168 | MST | 2.07 | ≤0.05 |
| 1515 | Methionine | 1.85 | ≤0.10 |
| 2252 | Spermidine | 1.85 | ≤0.10 |
| 1645 | Arabinose | 1.71 | ≤0.10 |
| 2208 | Linoleate | -1.72 | ≤0.10 |
| 2216 | Linolenate | -1.72 | ≤0.10 |
| 1263 | Ethanolamine | -1.72 | ≤0.10 |
| 1441 | PR-MST | -1.72 | ≤0.10 |
| 2752 | Sugar disaccharide | 6.97 | ≤0.001 |
| 1104 | PR-MST | 1.99 | ≤0.05 |
| 2404 | Inositol-1-phosphate | 1.99 | ≤0.05 |
| 1773 | PR-MST | 1.81 | ≤0.10 |
Abbreviations: RI, retention index; MST, mass spectral tag obtained from the Golm Metabolome Database (GMD) [30]; PR-MST, Platform for RIKEN Metabolome (PRIMe)-mass spectral tag defined by our custom library for GC-MS spectra at PRIMe.
Figure 7Schematic flowchart of the coexpression analysis of genes based on metabolite correlations by using public transcriptome databases. The process consists of 4 steps: (1) metabolite-metabolite correlation analysis, (2) extraction of enzyme-coding genes from the AraCyc pathways, (3) coexpression analysis of the extracted enzyme-coding gene pairs, and (4) coexpression analysis of genes encoding transcription factors with the coexpressed pairs of enzyme-coding genes. Abbreviations: r, weighted Pearson's correlation coefficient of a pair of enzyme-coding genes for metabolites X and Y; r, weighted Pearson's correlation coefficient of the common transcription factor (TF) gene that is coexpressed with both the enzyme-coding genes of metabolites X and Y.